Eli Lilly Jumps 8% as Strong Quarter Lifts Revenue Outlook; Novo Nordisk Ticks Up, Viking Therapeutics Eases24/7 Wall Street • Thursday
Novo Nordisk (NVO) Stock Declines While Market Improves: Some Information for InvestorsZacks Investment Research • Tuesday
Novo Nordisk Vs. Eli Lilly Q3 Preview: I'd (Now) Buy Both, But Lilly Is My Top PickSeeking Alpha • Tuesday
Amgen vs. Novo Nordisk: Which Healthcare Giant's Stock Is a Better Buy in 2026?The Motley Fool • Tuesday
GLP-1 boom in China, India, Brazil could create $22 bln market by 2035, J.P. Morgan saysReuters • 10/23/26
Eli Lilly Rises 4% While Foundayo Nears European Approval; Amgen and Novo Nordisk Edge Higher24/7 Wall Street • 10/20/26
Novo's next-generation obesity drug shows 25% weight loss in women in late-stage analysisCNBC • 10/20/26